US 11815516
Protein biomarkers for diseases associated with the contact activation system
granted A61KA61K38/08A61P
Quick answer
US patent 11815516 (Protein biomarkers for diseases associated with the contact activation system) held by Takeda Pharmaceutical Company Limited expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/08, A61P, A61P43/00, A61P7/10